FTC Warns FDA That Biologic Suffixes Will Curb Competition

 
• By David Wallace
  
AirBalloons
FDA Biologic Naming Proposals Will Drag Down Biosimilars, The FTC Says • Source: Shutterstock
Generics Bulletin Podcast

Stay ahead of every shift in generics and biosimilars.

Generics Bulletin brings you the latest updates that matter for the off-patent industry.

SpotifyApple PodcastsWebsite

More from Regulation

More from Policy & Regulation